Jim Simons Armata Pharmaceuticals, Inc. Transaction History

Renaissance Technologies LLC

$70.6 Billion
Q3 2025

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Armata Pharmaceuticals, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 41,296 shares of ARMP stock, worth $290,723. This represents 0.0% of its overall portfolio holdings.

Number of Shares

41,296

Previous 38,896 6.17%

Holding current value

$290,723

Previous $73,000 71.23%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$1.92 - $3.07 $4,608 - $7,368	2,400 Added 6.17%	41,296 $125,000
Q2 2025 Aug 13, 2025	BUY	$0.9 - $2.37 $270 - $711	300 Added 0.78%	38,896 $73,000
Q1 2025 May 14, 2025	SELL	$1.46 - $2.19 $2,474 - $3,712	-1,695 Reduced 4.21%	38,596 $56,000
Q4 2024 Feb 13, 2025	SELL	$1.85 - $2.82 $11,479 - $17,498	-6,205 Reduced 13.35%	40,291 $74,000
Q3 2024 Nov 13, 2024	SELL	$2.1 - $3.3 $3,570 - $5,610	-1,700 Reduced 3.53%	46,496 $110,000

Q2 2024 Aug 09, 2024	SELL	$2.4 - $3.9 $7,680 - $12,480	-3,200 Reduced 6.23%	48,196 $132,000
Q1 2024 May 13, 2024	SELL	$2.81 - $4.18 $6,182 - $9,196	-2,200 Reduced 4.1%	51,396 $215,000
Q4 2023 Feb 13, 2024	SELL	$1.95 - $3.24 $7,605 - $12,636	-3,900 Reduced 6.78%	53,596 $174,000
Q3 2023 Nov 14, 2023	SELL	$1.1 - $4.35 $5,390 - $21,315	-4,900 Reduced 7.85%	57,496 $172,000
Q2 2023 Aug 11, 2023	SELL	$1.14 - $1.7 $911 - $1,360	-800 Reduced 1.27%	62,396 $71,000
Q1 2023 May 12, 2023	SELL	$1.1 - $3.58 $11,550 - $37,590	-10,500 Reduced 14.25%	63,196 $106,000
Q4 2022 Feb 13, 2023	BUY	$0.94 - $4.16 $3,666 - $16,224	3,900 Added 5.59%	73,696 $91,000
Q3 2022 Nov 14, 2022	SELL	$3.12 - $4.92 $31,824 - $50,184	-10,200 Reduced 12.75%	69,796 $295,000
Q2 2022 Aug 12, 2022	SELL	$2.97 - $5.4 $5,049 - $9,180	-1,700 Reduced 2.08%	79,996 $311,000
Q1 2022 May 13, 2022	SELL	$3.9 - $6.32 $12,090 - $19,592	-3,100 Reduced 3.66%	81,696 $399,000
Q4 2021 Feb 11, 2022	SELL	$2.96 - $5.86 $63,036 - $124,794	-21,296 Reduced 20.07%	84,796 $465,000
Q3 2021 Nov 12, 2021	SELL	$3.55 - $4.14 $37,644 - $43,900	-10,604 Reduced 9.09%	106,092 $384,000
Q2 2021 Aug 13, 2021	SELL	$3.89 - $4.87 $27,696 - $34,674	-7,120 Reduced 5.75%	116,696 $463,000
Q1 2021 May 13, 2021	BUY	$3.02 - $6.33 $74,956 - $157,110	24,820 Added 25.07%	123,816 $592,000
Q4 2020 Feb 10, 2021	BUY	$2.65 - $3.94 $14,039 - $20,874	5,298 Added 5.65%	98,996 $295,000
Q3 2020 Nov 13, 2020	BUY	$2.96 - $4.04 $26,110 - $35,636	8,821 Added 10.39%	93,698 $299,000
Q2 2020 Aug 13, 2020	BUY	$2.98 - $4.2 $54,087 - $76,230	18,150 Added 27.2%	84,877 $333,000
Q1 2020 May 14, 2020	SELL	$2.58 - $4.85 $19,161 - $36,020	-7,427 Reduced 10.02%	66,727 $207,000
Q4 2019 Feb 13, 2020	SELL	$3.16 - $4.54 $4,740 - $6,810	-1,500 Reduced 1.98%	74,154 $241,000
Q3 2019 Nov 13, 2019	BUY	$3.35 - $4.72 $2,680 - $3,776	800 Added 1.07%	75,654 $280,000
Q2 2019 Aug 12, 2019	BUY	$2.75 - $5.6 $205,848 - $419,182	74,854 New	74,854 $300,000

Others Institutions Holding ARMP

# of Institutions

Shares Held

755K

Call Options Held

Put Options Held

View Full List

About Armata Pharmaceuticals, Inc.

Ticker ARMP
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,144,700
Market Cap $254M
Description
Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus ...

More about ARMP

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account